Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
11 hedge funds and large institutions have $4.3M invested in Timber Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 → 11 (+1)
43% less capital invested
Capital invested by funds: $7.53M → $4.3M (-$3.24M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$135K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$22.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$11.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
-$377K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$160K |
| 3 |
LPL Financial
San Diego,
California
|
-$11.2K |
| 4 |
TCM
Tenor Capital Management
New York
|
-$11.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $3.02M | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $622K | +$135K | +12 | +23% |
|
|
RI
3
RTW Investments
New York
| $455K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $100K | – | – | – |
|
|
TCM
5
Tenor Capital Management
New York
| $26K | -$11.2K | -1 | -25% |
|
|
6
LPL Financial
San Diego,
California
| $25K | -$11.2K | -1 | -25% |
|
|
VKH
7
Virtu KCG Holdings
New York
| $19K | +$22.4K | +2 | New |
|
8
Citadel Advisors
Miami,
Florida
| $9K | – | – | – |
|
|
TSS
9
Two Sigma Securities
New York
| $9K | +$11.2K | +1 | New |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $7K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $7K | +$11.2K | +1 | New |
|
|
BFA
12
BlackRock Fund Advisors
San Francisco,
California
| $1K | – | – | – |
|
|
NC
13
Nexthera Capital
New York
| – | -$377K | -23 | Closed |
|
|
DCM
14
DAFNA Capital Management
Los Angeles,
California
| – | -$160K | -10 | Closed |
|
TMBR Hedge Fund Activity: Q2 2016 in Review
11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q2 2016, worth a combined $4.3M — down 43% from $7.53M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TMBR positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, adding an estimated $135K. The largest seller was Nexthera Capital, exiting entirely with an estimated $377K sold.
- 11 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q2 2016, up from 10 in Q1 2016.
- Funds reported $4.3M of Timber Pharmaceuticals, Inc. stock for Q2 2016, down 43% quarter-over-quarter.
- 3 funds opened new Timber Pharmaceuticals, Inc. positions in Q2 2016 and 2 closed out, a net change of +1 holder.
- The largest Timber Pharmaceuticals, Inc. buyer in Q2 2016 was Sabby Management, an estimated $135K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q2 2016 was Nexthera Capital, an estimated $377K sold.
Based on aggregated 13F filings for Q2 2016.